Aromatase inhibitor: Difference between revisions
Jump to navigation
Jump to search
imported>David E. Volk m (→References) |
imported>David E. Volk m (Aromatase inhibitors moved to Aromatase inhibitor) |
(No difference)
| |
Revision as of 16:37, 31 May 2009
Aromatase inhibitors, which inhibit the enzyme aromatase used biologically to produce estrogens, inhibit the biosynthetic production of estrogen steroids. Because of this action, these inhibitors are sometimes used to treat cancerous tumors which are estrogen-sensitive. At present, three AIs are approved by the FDA[1] :
- anastrazole (Arimidex®)
- exemestane (Aromasin®)
- letrozole (Femara®)